152 related articles for article (PubMed ID: 23249450)
21. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
22. The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients.
Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Yilmaz C
Int J Immunogenet; 2009 Oct; 36(5):283-8. PubMed ID: 19744034
[TBL] [Abstract][Full Text] [Related]
23. Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.
Patel SS; Truong U; King M; Ferland A; Moreau KL; Dorosz J; Hokanson JE; Wang H; Kinney GL; Maahs DM; Eckel RH; Nadeau KJ; Cree-Green M
Vasc Med; 2017 Apr; 22(2):85-95. PubMed ID: 28095749
[TBL] [Abstract][Full Text] [Related]
24. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
25. Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test.
Yildir IC; Kutluturk F; Tasliyurt T; Yelken BM; Acu B; Beyhan M; Erkorkmaz U; Yilmaz A
Gynecol Endocrinol; 2013 Feb; 29(2):148-51. PubMed ID: 23127112
[TBL] [Abstract][Full Text] [Related]
26. Retinol-binding protein in nonobese women with polycystic ovary syndrome.
Lee JW; Im JA; Lee DC; Lee HR; Shim JY
Clin Endocrinol (Oxf); 2008 May; 68(5):786-90. PubMed ID: 17986278
[TBL] [Abstract][Full Text] [Related]
27. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
[TBL] [Abstract][Full Text] [Related]
28. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).
Barrea L; Arnone A; Annunziata G; Muscogiuri G; Laudisio D; Salzano C; Pugliese G; Colao A; Savastano S
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547562
[TBL] [Abstract][Full Text] [Related]
29. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
30. Serum sclerostin level and its relation to subclinical atherosclerosis in the polycystic ovary syndrome phenotypes: A prospective controlled study.
İncesu Çintesun FN; Can Ü; Çintesun E; Altunkeser A; Kaya A; Günenç O
Turk J Obstet Gynecol; 2021 Sep; 18(3):167-174. PubMed ID: 34580388
[TBL] [Abstract][Full Text] [Related]
31. Association of clinical androgen excess with radial artery intima media thickness in women with polycystic ovary syndrome.
Yilmaz SA; Kebapcilar A; Koplay M; Kerimoglu OS; Pekin AT; Gencoglu B; Dogan NU; Celik C
Gynecol Endocrinol; 2015 Jun; 31(6):477-82. PubMed ID: 26213862
[TBL] [Abstract][Full Text] [Related]
32. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
33. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF
Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
[TBL] [Abstract][Full Text] [Related]
34. Does cardiovascular risk vary according to the criteria for a diagnosis of polycystic ovary syndrome?
Ramoglu S; Yoldemir T; Atasayan K; Yavuz DG
J Obstet Gynaecol Res; 2017 Dec; 43(12):1848-1854. PubMed ID: 28892255
[TBL] [Abstract][Full Text] [Related]
35. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
36. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome.
Vipin VP; Dabadghao P; Shukla M; Kapoor A; Raghuvanshi AS; Ramesh V
Fertil Steril; 2016 May; 105(5):1338-1344.e3. PubMed ID: 26852421
[TBL] [Abstract][Full Text] [Related]
38. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
Chen Y; Wang XJ; Jin HL; Jin L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
[TBL] [Abstract][Full Text] [Related]
39. Study of early atherosclerotic markers in women with polycystic ovary syndrome.
Karoli R; Fatima J; Siddiqi Z; Vatsal P; Sultania AR; Maini S
Indian J Endocrinol Metab; 2012 Nov; 16(6):1004-8. PubMed ID: 23226652
[TBL] [Abstract][Full Text] [Related]
40. Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women.
de Medeiros SF; Ormond CM; de Medeiros MAS; de Souza Santos N; Banhara CR; Yamamoto MMW
Endocr Connect; 2017 Oct; 6(7):479-488. PubMed ID: 28784626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
